Pro-apoptotic  	Pro-apoptotic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
splice-switching  	splice-switching  	 JJ	O
oligonucleotides  	oligonucleotides  	 NNS	B-NP
targeting  	targeting  	 VBG	I-NP
Bcl-x  	Bcl-x  	 JJ	I-NP
pre-mRNA  	pre-mRNA  	 NN	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
glioma  	glioma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines  	lines  	 NNS	I-NP
Alternative  	Alternative  	 JJ	O
splicing  	splicing  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
near-ubiquitous  	near-ubiquitous  	 JJ	B-NP
phenomenon  	phenomenon  	 NN	I-NP
with  	with  	 IN	O
important  	important  	 JJ	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
human  	human  	 JJ	O
diseases 	diseases 	 NNS	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
cancers 	cancers 	 NNS	I-NP
.  	.  	 .	O
Splice-switching  	Splice-switching  	 JJ	B-NP
oligonucleotides  	oligonucleotides  	 NNS	I-NP
( 	( 	 -LRB-	O
SSOs 	SSOs 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
emerged  	emerged  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
class  	class  	 NN	O
of  	of  	 IN	O
antisense  	antisense  	 JJ	B-NP
therapeutics  	therapeutics  	 NN	I-NP
that  	that  	 WDT	O
modulate  	modulate  	 VBP	O
alternative  	alternative  	 JJ	O
splicing  	splicing  	 NN	O
by  	by  	 IN	O
hybridizing  	hybridizing  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
pre-mRNA  	pre-mRNA  	 JJ	B-NP
splice  	splice  	 JJ	I-NP
site 	site 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Bcl-x  	Bcl-x  	 JJ	B-NP
gene  	gene  	 NN	I-NP
is  	is  	 VBZ	O
alternatively  	alternatively  	 RB	O
spliced  	spliced  	 VBN	O
to  	to  	 TO	O
express  	express  	 VB	O
anti‑apoptotic  	anti‑apoptotic  	 NNP	B-NP
Bcl-xL  	Bcl-xL  	 NNP	O
and  	and  	 CC	O
pro-apoptotic  	pro-apoptotic  	 JJ	B-NP
Bcl-xS 	Bcl-xS 	 NN	I-NP
.  	.  	 .	O
Bcl-xL  	Bcl-xL  	 JJ	B-NP
expression  	expression  	 NN	I-NP
is  	is  	 VBZ	O
upregulated  	upregulated  	 VBN	O
in  	in  	 IN	O
many  	many  	 JJ	O
cancers  	cancers  	 NNS	O
and  	and  	 CC	O
is  	is  	 VBZ	O
considered  	considered  	 VBN	O
a  	a  	 DT	O
general  	general  	 JJ	O
mechanism  	mechanism  	 NN	O
by  	by  	 IN	O
which  	which  	 WDT	O
cancer  	cancer  	 NN	B-NP
cells  	cells  	 NNS	I-NP
evade  	evade  	 JJ	O
apoptosis 	apoptosis 	 NN	B-NP
.  	.  	 .	O
By  	By  	 IN	O
redirecting  	redirecting  	 JJ	B-NP
Bcl-x  	Bcl-x  	 JJ	I-NP
pre-mRNA  	pre-mRNA  	 JJ	I-NP
splicing  	splicing  	 NN	I-NP
from  	from  	 IN	O
Bcl-xL  	Bcl-xL  	 JJ	B-NP
to  	to  	 TO	O
Bcl-xS 	Bcl-xS 	 JJ	B-NP
,  	,  	 ,	O
SSO  	SSO  	 NNP	B-NP
exerted  	exerted  	 VBD	I-NP
pro-apoptotic  	pro-apoptotic  	 JJ	I-NP
and  	and  	 CC	O
chemosensitizing  	chemosensitizing  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
in  	in  	 IN	O
various  	various  	 JJ	O
cancer  	cancer  	 NN	B-NP
cell  	cell  	 NN	I-NP
lines 	lines 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
SSO  	SSO  	 NNP	B-NP
targeting  	targeting  	 VBG	I-NP
Bcl-x  	Bcl-x  	 JJ	I-NP
pre-mRNA  	pre-mRNA  	 NN	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
glioma  	glioma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines 	lines 	 NNS	I-NP
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
we  	we  	 PRP	O
performed  	performed  	 VBD	B-NP
reverse  	reverse  	 RB	I-NP
transcription-polymerase  	transcription-polymerase  	 JJ	I-NP
chain  	chain  	 NN	I-NP
reaction  	reaction  	 NN	I-NP
( 	( 	 -LRB-	O
RT-PCR 	RT-PCR 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
western  	western  	 JJ	O
blotting  	blotting  	 NN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
mRNA  	mRNA  	 JJ	O
and  	and  	 CC	O
protein  	protein  	 NN	B-NP
expression  	expression  	 NN	I-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
Bcl-xL  	Bcl-xL  	 JJ	I-NP
in  	in  	 IN	O
glioma  	glioma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines  	lines  	 NNS	I-NP
( 	( 	 -LRB-	O
U87  	U87  	 NNP	B-NP
and  	and  	 CC	O
U251 	U251 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
a  	a  	 DT	O
normal  	normal  	 JJ	B-NP
human  	human  	 JJ	I-NP
astrocyte  	astrocyte  	 JJ	I-NP
cell  	cell  	 NN	I-NP
line  	line  	 NN	I-NP
( 	( 	 -LRB-	O
HA1800 	HA1800 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Then 	Then 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
Bcl-x  	Bcl-x  	 JJ	B-NP
SSO  	SSO  	 NNP	I-NP
was  	was  	 VBD	O
designed  	designed  	 VBN	O
to  	to  	 TO	O
bind  	bind  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
downstream  	downstream  	 JJ	O
5 	5 	 CD	O
'  	'  	 POS	O
alternative  	alternative  	 JJ	O
splice  	splice  	 JJ	O
site  	site  	 NN	O
of  	of  	 IN	O
exon 2  	exon 2  	 CD	B-NP
in  	in  	 IN	O
Bcl-x  	Bcl-x  	 JJ	B-NP
pre-mRNA  	pre-mRNA  	 JJ	I-NP
and  	and  	 CC	O
was  	was  	 VBD	O
modified  	modified  	 VBN	O
using  	using  	 VBG	O
2 	2 	 CD	O
' 	' 	 POS	B-NP
-O-methoxyethyl-phosphorothioate 	-O-methoxyethyl-phosphorothioate 	 JJ	I-NP
.  	.  	 .	O
An  	An  	 DT	O
oligonucleotide  	oligonucleotide  	 NN	B-NP
targeting  	targeting  	 VBG	O
aberrantly  	aberrantly  	 JJ	B-NP
spliced  	spliced  	 JJ	I-NP
human  	human  	 JJ	I-NP
β-globin  	β-globin  	 JJ	I-NP
intron  	intron  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
negative  	negative  	 JJ	B-NP
control 	control 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
SSOs  	SSOs  	 NN	B-NP
were  	were  	 VBD	O
delivered  	delivered  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
cationic  	cationic  	 JJ	B-NP
lipid  	lipid  	 NN	I-NP
into  	into  	 IN	O
glioma  	glioma  	 NN	B-NP
and  	and  	 CC	O
astrocyte  	astrocyte  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines 	lines 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
antitumor  	antitumor  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
SSOs  	SSOs  	 NN	I-NP
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
3- 	3- 	 NNP	O
( 	( 	 -LRB-	O
4,5-dimethylthiazol-2-yl 	4,5-dimethylthiazol-2-yl 	 NNP	O
) 	) 	 -RRB-	O
-2,5-diphenyltetrazolium  	-2,5-diphenyltetrazolium  	 FW	O
bromide  	bromide  	 FW	O
assays  	assays  	 FW	O
and  	and  	 CC	O
flow  	flow  	 NN	B-NP
cytometry 	cytometry 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
switch  	switch  	 NN	O
in  	in  	 IN	O
production  	production  	 NN	O
from  	from  	 IN	O
Bcl-xL  	Bcl-xL  	 JJ	B-NP
to  	to  	 TO	O
Bcl-xS  	Bcl-xS  	 NNP	B-NP
was  	was  	 VBD	O
analyzed  	analyzed  	 VBN	O
by  	by  	 IN	O
RT-PCR  	RT-PCR  	 JJ	B-NP
and  	and  	 CC	O
western  	western  	 JJ	O
blotting 	blotting 	 NN	O
.  	.  	 .	O
Bcl-xL  	Bcl-xL  	 NNP	B-NP
mRNA  	mRNA  	 NNP	I-NP
and  	and  	 CC	O
protein  	protein  	 NN	B-NP
were  	were  	 VBD	O
highly  	highly  	 RB	O
expressed  	expressed  	 VBN	O
in  	in  	 IN	O
both  	both  	 DT	O
glioma  	glioma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines 	lines 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Bcl-x  	Bcl-x  	 JJ	B-NP
SSO  	SSO  	 NNS	I-NP
modified  	modified  	 VBN	I-NP
Bcl-x  	Bcl-x  	 JJ	I-NP
pre-mRNA  	pre-mRNA  	 JJ	I-NP
splicing  	splicing  	 NN	I-NP
and  	and  	 CC	O
had  	had  	 VBD	O
pro-apoptotic  	pro-apoptotic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
glioma  	glioma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines 	lines 	 NNS	I-NP
.  	.  	 .	O
By  	By  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
lipid  	lipid  	 NN	B-NP
alone  	alone  	 RB	O
and  	and  	 CC	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
SSO  	SSO  	 NNP	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
affect  	affect  	 VB	O
Bcl-xL  	Bcl-xL  	 JJ	B-NP
expression  	expression  	 NN	I-NP
or  	or  	 CC	O
induce  	induce  	 VB	O
apoptosis 	apoptosis 	 NNS	B-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
study  	study  	 NN	O
demonstrated  	demonstrated  	 VBD	O
the  	the  	 DT	O
antitumor  	antitumor  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
SSO  	SSO  	 NN	B-NP
that  	that  	 WDT	O
targets  	targets  	 VBZ	O
Bcl-x  	Bcl-x  	 JJ	B-NP
pre-mRNA  	pre-mRNA  	 JJ	I-NP
splicing  	splicing  	 NN	I-NP
in  	in  	 IN	O
glioma  	glioma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lines 	lines 	 NNS	I-NP
.  	.  	 .	O
Bcl-x  	Bcl-x  	 NNP	B-NP
SSO  	SSO  	 NNP	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
strategy  	strategy  	 NN	I-NP
for  	for  	 IN	I-NP
treating  	treating  	 VBG	I-NP
gliomas 	gliomas 	 NNS	I-NP
.  	.  	 .	O
